APA (7th ed.) Citation

ME, P., HL, M., M, W., A, T., H, P., AP, T., . . . FS, D. (2025). Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR. Morbidity and mortality weekly report, 74(16), 273. https://doi.org/10.15585/mmwr.mm7416a1

Chicago Style (17th ed.) Citation

ME, Patton, et al. "Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025." MMWR. Morbidity and Mortality Weekly Report 74, no. 16 (2025): 273. https://doi.org/10.15585/mmwr.mm7416a1.

MLA (9th ed.) Citation

ME, Patton, et al. "Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025." MMWR. Morbidity and Mortality Weekly Report, vol. 74, no. 16, 2025, p. 273, https://doi.org/10.15585/mmwr.mm7416a1.